Bladder cancer Board decisions

The Board has found a need for additional examination to determine if the Veteran's urinary frequency is due to his service-connected bladder cancer. The effective date of March 14, 2017 remains unchanged as it was when the law allowed presumptive service connection for bladder cancer based on exposure at Camp Lejeune.

The Veteran's appeal for bladder cancer, which was granted as a result of new legislation making it presumptively associated with herbicide exposure, has been withdrawn by the Veteran and his representative. As a result, the claim is dismissed without prejudice.

The earlier effective date for a 30% rating for hearing loss is dismissed.,The previously denied claim for severe skin diseases has been reopened, but the issue of an earlier effective date remains unresolved.,The Veteran's claims for sleep apnea, diabetes mellitus type II, bladder cancer, ischemic heart disease, and neuropathy associated with diabetes mellitus type II are remanded due to insufficient evidence on their etiology.,Service connection is granted for diabetes mellitus type II, bladder cancer, ischemic heart disease, and neuropathy associated with diabetes mellitus type II.,The earlier effective date for the hearing loss rating remains unresolved.,The previously denied claim for severe skin diseases has been reopened, but an earlier effective date issue remains unresolved.,Service connection is granted for sleep apnea.

The Veteran's service connection claims for metastatic kidney cancer, bladder cancer, nephrectomy of the right kidney secondary to kidney cancer, and spine cancer are all granted due to presumed exposure to contaminated water at Camp Lejeune.

The Veteran's bladder cancer is granted service connection due to exposure at Camp Lejeune. The male reproductive organ disorder and PTSD evaluation are remanded for further review.

The Veteran's claims for service connection are remanded due to insufficient evidence regarding in-service exposure to herbicide agents and the need for additional medical opinions on various musculoskeletal conditions, liver condition, bladder cancer, chronic kidney disease, respiratory condition, and colon condition.

The Board has determined that additional development is needed to determine the etiology of the Veteran's bladder cancer and cerebrovascular accident (CVA). The issues remain inextricably intertwined due to the Veteran's claim that his CVA was caused by his bladder cancer.

Your bladder cancer claim was denied in 2014, but it was granted again in 2022. Since the grant of service connection, there are no more issues to appeal.

The Veteran's claim for an earlier effective date for service connection of bladder cancer was denied as he did not meet the criteria at the time of the March 2017 regulatory change allowing presumptive service connection.

The Veteran's claim for service connection for bladder cancer has been fully granted. The appeal for hepatitis (B or C variant) is remanded.

The Veteran's claims for service connection for various conditions, including bladder cancer and insomnia, have been granted. The claim for a right shoulder disorder is remanded.

The Veteran's claims for service connection for various conditions, including respiratory illness (allergic rhinitis with sinusitis), nosebleeds, heart condition, hypertension, thyromegaly, prostate cancer, bladder cancer, and diabetes mellitus have been granted. The decision also remanded the claim for service connection for nosebleeds as secondary to sinusitis.

The Board has dismissed the appeal for service connection for obstructive sleep apnea and granted service connection for bladder cancer, presumptively due to exposure to herbicide agents.

The Board has remanded the claims for service connection due to insufficient information regarding the Veteran's exposure to herbicide agents during his service aboard USS America. The Appellant must provide further evidence or clarification.

The Board has determined that there is not substantial compliance with prior remand directives and additional development is needed to determine the Veteran's exposure to ionizing radiation during service, as well as whether his cancers are related to such exposure. The claims for service connection for prostate cancer, colon cancer, bladder cancer, kidney cancer, and skin cancer are being remanded.

The Veteran withdrew all his appeals, including those for bilateral hearing loss, bladder cancer, left upper extremity neuropathy, right upper extremity neuropathy, and lumbar spine disability. The Board dismissed these claims as a result.

The Veteran's bladder cancer is granted service connection based on presumed exposure to herbicide agents. The issues of an increased rating for PTSD, service connection for bilateral hearing loss, and service connection for tinnitus are remanded.

The Veteran's bladder cancer was granted service connection with a 100% evaluation effective March 14, 2017. The Board is remanding the case to determine if earlier service connection could be established based on early symptoms in service and exposure at Camp Lejeune.

The Board has remanded the case due to insufficient evidence regarding the Veteran's exposure to Agent Orange and the correct diagnosis of his cancer. The VA must obtain further information about whether the Veteran was exposed to Agent Orange during his service in South Korea, specifically at Camp Page near the DMZ. Additionally, a medical opinion is needed to determine if the Veteran's urethral or bladder cancer were caused by Agent Orange exposure.

The Veteran's claim for service connection for bladder cancer was granted, effective January 18, 2007. As the issue has been resolved in favor of the Veteran, it is now moot and dismissed.